About Adaptive Biotechnologies Adaptive Biotechnologies is a commercial-stage biotechnology company focused on translating the genetic language of the adaptive immune system into clinical products to diagnose and treat disease. Quick Links Stock Governance Filings Press Releases Adaptive Biotechnologies Reports Third Quarter 2023 Financial Results and Provides Business Update 11-09-2023 at 4:06 PM EST Adaptive Biotechnologies Announces New Translational Collaboration to Measure Minimal Residual Disease with clonoSEQ® Assay Across BeiGene’s Lymphoid Malignancy Pipeline 11-07-2023 at 7:30 AM EST Adaptive Biotechnologies to Report Third Quarter Financial Results on November 9, 2023 11-02-2023 at 4:07 PM EDT VIEW ALL NEWS Upcoming Events & Presentations More events are coming soon. Past Events & Presentations Adaptive Biotechnologies Third Quarter Financial Results Nov 9, 2023 at 4:30 PM EST Listen to webcast Adaptive Biotechnologies Q3 2023 Earnings Presentation 941.8 KB Morgan Stanley 21st Annual Global Healthcare Conference Sep 13, 2023 at 1:35 PM EDT Listen to webcast Adaptive Biotechnologies Second Quarter Financial Results Aug 2, 2023 at 4:30 PM EDT Listen to webcast Adaptive Biotechnologies Q2 2023 Earnings Presentation 1.2 MB VIEW ALL EVENTS CHANGE VOLUME 52 week high 52 week LOW MARKET CAP Dec 3, 2023 6:52 AM ESTData Provided by Refinitiv. Minimum 15 minutes delayed.
